This Webcast focuses on the role of Enzalutamide, a second generation androgen receptor inhibitor for the treatment of men with metastatic prostate cancer. It covers advances in management of mCRPC and mCSPC and provides practical tips while prescribing Enzalutamide. The speaker also covers decision making algorithm in management of metastatic prostate cancer.